Filters

Arformoterol manufacturers

Filters

arformoterol

Inhalation solution tbd

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Manufacturer #13159

This company is a driving force in developing innovative treatments and technologies for a range of medical needs. Focusing on areas like psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy, they have a diverse pipeline of preclinical and clinical programs. Their technology-driven approach aims to bring patient-first solutions to market faster. While specific details about their production lines (prescription medications, over-the-counter drugs, medical devices, supplements) and GMP certifications are not provided, their commitment to research and development in key therapy areas suggests a broad scope of products. The company operates in regions like the EU and North America, emphasizing global impact.

arformoterol

Nebuliser solution 15 mcg - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
ANVISA, TGA, INVIMA
Manufacturer #36629

Established in 1993, this manufacturer employs over 1,100 staff and operates advanced production lines for metered dose inhalers, nasal sprays, dry powder inhalers, and nebulizer solutions. As a CTD dossier owner and manufacturer, it holds GMP approvals from more than 20 countries, including Australia. The manufacturer is recognized as a CTD dossier owner and manufacturer, and its products are distributed in over 90 countries worldwide. With a focus on innovation, the manufacturer is a CTD dossier owner and manufacturer, dedicated to developing high-end generic drugs

Manufacturer usually replies in 30 days

arformoterol

Inhalation solution 15 mcg - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
FDA, PICS, China
MAs available in
United States
Manufacturer #20131

This fully integrated specialty pharmaceutical company focuses on researching, manufacturing, and marketing respiratory drug products globally. Their therapeutic areas include allergic rhinitis, asthma, COPD, respiratory infections, pulmonary fibrosis, and pulmonary hypertension. They offer various dosage forms, including inhalation sprays (SMI), metered-dose inhalers (MDI), dry powder inhalers (DPI), nebulizations, nasal sprays, and liposomes. The company boasts over 30 patents and a team of more than 100 R&D personnel. They have received recognition as a top employer in their region and secured significant funding to support the development of high-end inhalation products. Their operations extend across key regions like the EU and North America.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.